Heat shock protein 90 targeting therapy: state of the art and future perspective

Authors

  • Manabu Tatokoro Department of Urology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan
  • Fumitaka Koga Department of Urology, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, Japan
  • Soichiro Yoshida Department of Urology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan
  • Kazunori Kihara Department of Urology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan

DOI:

https://doi.org/10.17179/excli2014-586

Keywords:

Hsp90 inhibitor, cancer, clinical trial, bladder cancer

Abstract

Heat shock protein 90 (Hsp90) is an ATP-dependent molecular chaperone that plays a role in stabilizing and activating more than 200 client proteins. It is required for the stability and function of numerous oncogenic signaling proteins that determine the hallmarks of cancer. Since the initial discovery of the first Hsp90 inhibitor in the 1970s, multiple phase II and III clinical trials of several Hsp90 inhibitors have been undertaken. This review provides an overview of the current status on clinical trials of Hsp90 inhibitors and future perspectives on novel anticancer strategies using Hsp90 inhibitors.

Downloads

Published

2015-01-06

How to Cite

Tatokoro, M., Koga, F., Yoshida, S., & Kihara, K. (2015). Heat shock protein 90 targeting therapy: state of the art and future perspective. EXCLI Journal, 14, 48–58. https://doi.org/10.17179/excli2014-586

Issue

Vol. 14 (2015)

Section

Review articles

License

Authors who publish in this journal agree to the following terms:

  • The authors keep the copyright and grant the journal the right of first publication under the terms of the Creative Commons Attribution license, CC BY 4.0. This licencse permits unrestricted use, distribution and reproduction in any medium, provided that the original work is properly cited.
  • The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
  • Because the advice and information in this journal are believed to be true and accurate at the time of publication, neither the authors, the editors, nor the publisher accept any legal responsibility for any errors or omissions presented in the publication. The publisher makes no guarantee, express or implied, with respect to the material contained herein.
  • The authors can enter into additional contracts for the non-exclusive distribution of the journal's published version by citing the initial publication in this journal (e.g. publishing in an institutional repository or in a book).